Ubs Group Ag Dare Bioscience, Inc. Call Options Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DARE
# of Institutions
10Shares Held
813KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY204KShares$916,3440.0% of portfolio
-
Two Sigma Securities, LLC New York, NY103KShares$463,0320.0% of portfolio
-
Interwest Venture Management CO62.1KShares$279,2920.14% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA35KShares$157,3110.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY15.3KShares$68,8590.0% of portfolio
About Dare Bioscience, Inc.
- Ticker DARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,820,896
- Market Cap $382M
- Description
- Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...